Identification of the EH CRISPR-Cas9 system on a metagenome and its application to genome engineering

Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10045/134143
Registro completo de metadatos
Registro completo de metadatos
Campo DCValorIdioma
dc.contributorMicrobiología Moleculares_ES
dc.contributor.authorEsquerra, Belén-
dc.contributor.authorBaquedano, Ignacio-
dc.contributor.authorRuiz, Raul-
dc.contributor.authorFernandez, Almudena-
dc.contributor.authorMontoliu, Lluis-
dc.contributor.authorMojica, Francisco J.M.-
dc.contributor.otherUniversidad de Alicante. Departamento de Fisiología, Genética y Microbiologíaes_ES
dc.date.accessioned2023-05-08T06:20:42Z-
dc.date.available2023-05-08T06:20:42Z-
dc.date.issued2023-04-25-
dc.identifier.citationMicrobial Biotechnology. 2023, 16(7): 1505-1523. https://doi.org/10.1111/1751-7915.14266es_ES
dc.identifier.issn1751-7915-
dc.identifier.urihttp://hdl.handle.net/10045/134143-
dc.description.abstractNon-coding RNAs (crRNAs) produced from clustered regularly interspaced short palindromic repeats (CRISPR) loci and CRISPR-associated (Cas) proteins of the prokaryotic CRISPR-Cas systems form complexes that interfere with the spread of transmissible genetic elements through Cas-catalysed cleavage of foreign genetic material matching the guide crRNA sequences. The easily programmable targeting of nucleic acids enabled by these ribonucleoproteins has facilitated the implementation of CRISPR-based molecular biology tools for in vivo and in vitro modification of DNA and RNA targets. Despite the diversity of DNA-targeting Cas nucleases so far identified, native and engineered derivatives of the Streptococcus pyogenes SpCas9 are the most widely used for genome engineering, at least in part due to their catalytic robustness and the requirement of an exceptionally short motif (5′-NGG-3′ PAM) flanking the target sequence. However, the large size of the SpCas9 variants impairs the delivery of the tool to eukaryotic cells and smaller alternatives are desirable. Here, we identify in a metagenome a new CRISPR-Cas9 system associated with a smaller Cas9 protein (EHCas9) that targets DNA sequences flanked by 5′-NGG-3′ PAMs. We develop a simplified EHCas9 tool that specifically cleaves DNA targets and is functional for genome editing applications in prokaryotes and eukaryotic cells.es_ES
dc.description.sponsorshipConselleria de Innovación, Universidades, Ciencia y Sociedad Digital, Generalitat Valenciana (CIUCSD), Grant/Award Numbers: PROMETEO/2017/129 and PROMETEO/2021/057. Ministerio de Ciencia e Innovación (MICINN), Grant/Award Numbers: RTI2018-101223-B-I00 and PID2021-127644OB-I00.es_ES
dc.languageenges_ES
dc.publisherApplied Microbiology Internationales_ES
dc.publisherJohn Wiley & Sonses_ES
dc.rights© 2023 The Authors. Microbial Biotechnology published by Applied Microbiology International and John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.es_ES
dc.subjectCas9es_ES
dc.subjectCRISPRes_ES
dc.subjectGenome editinges_ES
dc.subjectMetagenomees_ES
dc.subjectRecombineeringes_ES
dc.titleIdentification of the EH CRISPR-Cas9 system on a metagenome and its application to genome engineeringes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.peerreviewedsies_ES
dc.identifier.doi10.1111/1751-7915.14266-
dc.relation.publisherversionhttps://doi.org/10.1111/1751-7915.14266es_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/RTI2018-101223-B-I00es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/PID2021-127644OB-I00es_ES
Aparece en las colecciones:INV - Microbiología Molecular - Artículos de Revistas

Archivos en este ítem:
Archivos en este ítem:
Archivo Descripción TamañoFormato 
ThumbnailEsquerra‐Ruvira_etal_2023_MicrobialBiotech.pdf2,52 MBAdobe PDFAbrir Vista previa


Este ítem está licenciado bajo Licencia Creative Commons Creative Commons